Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goetz H Kloecker

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Current Problems in Cancer|November 17, 2019
Harlequin sign in Pancoast tumorRohit Kumar, Shruti Bhandari, Goetz H Kloecker
European Journal of Haematology|March 3, 2007
Argatroban for anticoagulation during cardiac surgeryMonte E Martin, Goetz H Kloecker, Damian A Laber
Clinical Advances in Hematology & Oncology : H&O|March 10, 2012
Radon and lung cancerTarsheen K Sethi, Moataz N El-Ghamry, Goetz H Kloecker
Oncotargets and Therapy|May 7, 2015
Novel targeted therapies for resistant ALK-rearranged non-small-cell lung cancer: ceritinib and beyondZeyad Kanaan, Goetz H Kloecker, Ajit Paintal, et al.
The American Journal of the Medical Sciences|December 19, 2008
Brain stem and clivus plasmacytomaGoetz H Kloecker, Chithra R Kannan, Damian A Laber, et al.
Oncotarget|April 19, 2015
CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinasesHina Mir, Rajesh Singh, Goetz H Kloecker, et al.
International Journal of Oncology|October 2, 2014
Expression and clinical significance of CXCR5/CXCL13 in human non‑small cell lung carcinomaRajesh Singh, Pranav Gupta, Goetz H Kloecker, et al.
The American Journal of the Medical Sciences|January 21, 2010
Fixed-dose every-other-week capecitabine and oxaliplatin for refractory squamous cell carcinoma of the head and neckGuilherme Rabinowits, Leela Bhupalam, Donald M Miller, et al.
Clinical Lung Cancer|March 18, 2009
Exosomal microRNA: a diagnostic marker for lung cancerGuilherme Rabinowits, Cicek Gerçel-Taylor, Jamie M Day, et al.
Journal of Cancer Policy|March 9, 2025
Patient-centered perspectives: Examining quality-of-life integration in recent phase III lung cancer trials (2019-2023)Shreyas Kalantri, Chiranjeevi Sainatham, Greeshma N Gaddipati, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Current Problems in Cancer|November 17, 2019
Harlequin sign in Pancoast tumorRohit Kumar, Shruti Bhandari, Goetz H Kloecker
European Journal of Haematology|March 3, 2007
Argatroban for anticoagulation during cardiac surgeryMonte E Martin, Goetz H Kloecker, Damian A Laber
Clinical Advances in Hematology & Oncology : H&O|March 10, 2012
Radon and lung cancerTarsheen K Sethi, Moataz N El-Ghamry, Goetz H Kloecker
Oncotargets and Therapy|May 7, 2015
Novel targeted therapies for resistant ALK-rearranged non-small-cell lung cancer: ceritinib and beyondZeyad Kanaan, Goetz H Kloecker, Ajit Paintal, et al.
The American Journal of the Medical Sciences|December 19, 2008
Brain stem and clivus plasmacytomaGoetz H Kloecker, Chithra R Kannan, Damian A Laber, et al.
Oncotarget|April 19, 2015
CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinasesHina Mir, Rajesh Singh, Goetz H Kloecker, et al.
International Journal of Oncology|October 2, 2014
Expression and clinical significance of CXCR5/CXCL13 in human non‑small cell lung carcinomaRajesh Singh, Pranav Gupta, Goetz H Kloecker, et al.
The American Journal of the Medical Sciences|January 21, 2010
Fixed-dose every-other-week capecitabine and oxaliplatin for refractory squamous cell carcinoma of the head and neckGuilherme Rabinowits, Leela Bhupalam, Donald M Miller, et al.
Clinical Lung Cancer|March 18, 2009
Exosomal microRNA: a diagnostic marker for lung cancerGuilherme Rabinowits, Cicek Gerçel-Taylor, Jamie M Day, et al.
Journal of Cancer Policy|March 9, 2025
Patient-centered perspectives: Examining quality-of-life integration in recent phase III lung cancer trials (2019-2023)Shreyas Kalantri, Chiranjeevi Sainatham, Greeshma N Gaddipati, et al.
Pageof 3